<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ea2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ea2</book-part-id>
      <title-group>
        <title>Episodic Ataxia Type 2</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Spacey</surname>
            <given-names>Sian</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Neurology<break/>University of British Columbia<break/>Vancouver, British Columbia, Canada</aff>
          <email>spacey@mail.ubc.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>2</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>15</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>30</day>
          <month>6</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ea1" document-type="chapter">Episodic Ataxia Type 1</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="epp-ar" document-type="chapter">Erythropoietic Protoporphyria, Autosomal Recessive</related-object>
      <abstract id="ea2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Episodic ataxia type 2 (EA2) is characterized by paroxysmal attacks of ataxia, vertigo, and nausea typically lasting minutes to days in duration. Attacks can be associated with dysarthria, diplopia, tinnitus, dystonia, hemiplegia, and headache. About 50% of individuals with EA2 have migraine headaches. Onset is typically in childhood or early adolescence (age range 2-32 years). Frequency of attacks can range from once or twice a year to three or four times a week. Attacks can be triggered by stress, exertion, caffeine, alcohol, fever, heat, and phenytoin; they can be stopped or decreased in frequency and severity by administration of acetazolamide or 4-aminopyridine. Between attacks, individuals may initially be asymptomatic but commonly develop interictal findings that can include nystagmus, pursuit and saccade alterations, and ataxia.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of EA2 is established by identification of a heterozygous pathogenic variant in <italic toggle="yes">CACNA1A</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Acetazolamide is effective in controlling or reducing the frequency and severity of attacks in most individuals; typical starting dose is 125 mg a day given orally, but doses as high as 500 mg twice a day may be required. Acetazolamide is generally well tolerated; the most common side effects are paresthesias of the extremities, rash, and renal calculi. Acetazolamide does not appear to prevent the progression of interictal symptoms. Studies have also demonstrated that 4-aminopyridine in doses of 5-10 mg/3x/day can also be effective in reducing attack frequency and duration.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual neurologic examination.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Phenytoin has been reported to exacerbate symptoms.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>EA2 is inherited in an autosomal dominant manner. Most individuals with a diagnosis of EA2 have an affected parent. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown. Offspring of affected individuals have a 50% chance of inheriting the pathogenic variant. Prenatal testing is possible for pregnancies at increased risk for EA2 if the pathogenic variant has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ea2.Diagnosis">
        <title>Diagnosis</title>
        <p>There are no formal clinical diagnostic criteria for the diagnosis of episodic ataxia type 2.</p>
        <sec id="ea2.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Episodic ataxia type 2 (EA2) <bold>should be suspected</bold> in individuals with the following clinical, neuroimaging, EMG, and family history findings.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Episodic attacks:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Including vertigo, gait and limb ataxia, and nystagmus lasting from five minutes to days, possibly associated with nausea and vomiting</p>
                </list-item>
                <list-item>
                  <p>Provoked by exercise, emotional stress, alcohol, caffeine, fever, and heat</p>
                </list-item>
                <list-item>
                  <p>Alleviated or prevented by acetazolamide therapy</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Presence of interictal ataxia and nystagmus</p>
            </list-item>
            <list-item>
              <p>Absence of myokymia (fine twitching or rippling of muscles) on physical examination</p>
            </list-item>
          </list>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Brain MRI may demonstrate atrophy of the cerebellar vermis [<xref ref-type="bibr" rid="ea2.REF.vighetto.1988.547">Vighetto et al 1988</xref>, <xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Nuclear magnetic spectroscopy may demonstrate abnormal cerebellar intracellular pH levels (in those not treated with acetazolamide) [<xref ref-type="bibr" rid="ea2.REF.bain.1992.147">Bain et al 1992</xref>] and low cerebellar creatine [<xref ref-type="bibr" rid="ea2.REF.harno.2005.542">Harno et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Myokymia is absent on EMG.</p>
            </list-item>
            <list-item>
              <p>Single fiber EMG may demonstrate jitter and blocking.</p>
            </list-item>
          </list>
          <p><bold>Family history</bold> consistent with autosomal dominant inheritance</p>
        </sec>
        <sec id="ea2.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of EA2 <bold>is established</bold> in a proband by the identification of a heterozygous pathogenic variant in <italic toggle="yes">CACNA1A</italic> by molecular genetic testing (see <xref ref-type="table" rid="ea2.T.molecular_genetic_testing_used_in">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">CACNA1A</italic> is performed first followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CACNA1A</italic> and other genes of interest (see <xref ref-type="sec" rid="ea2.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered.</p>
              <p>Note: (1) The genes included and sensitivity of multi-gene panels vary by laboratory and over time. (2) Guidelines for the molecular diagnosis of genetic conditions that cause ataxia have been published [<xref ref-type="bibr" rid="ea2.REF.gasser.2010.179">Gasser et al 2010</xref>].</p>
            </list-item>
          </list>
          <table-wrap id="ea2.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Episodic Ataxia Type 2</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CACNA1A</italic>
                  </td>
                  <td headers="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_ea2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ea2.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ea2" object-id="ea2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ea2.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ea2.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ea2.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ea2.TF.1.4">
                <label>4. </label>
                <p>In families linked to chromosome 19</p>
              </fn>
              <fn id="ea2.TF.1.5">
                <label>5. </label>
                <p>Sequence analysis has identified a number of <italic toggle="yes">CACNA1A</italic> pathogenic variants [<xref ref-type="bibr" rid="ea2.REF.yue.1998.298">Yue et al 1998</xref>, <xref ref-type="bibr" rid="ea2.REF.friend.1999.261">Friend et al 1999</xref>, <xref ref-type="bibr" rid="ea2.REF.denier.2001.292">Denier et al 2001</xref>]. In the study of <xref ref-type="bibr" rid="ea2.REF.jen.2004.17">Jen et al [2004]</xref>, nine (82%) of 11 families with episodic ataxia showed linkage to 19p; pathogenic variants in <italic toggle="yes">CACNA1A</italic> were identified in all nine families. In the same study, four of nine simplex cases (i.e., individuals with no family history of EA2) had identifiable <italic toggle="yes">CACNA1A</italic> pathogenic variants.</p>
              </fn>
              <fn id="ea2.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="ea2.TF.1.7">
                <label>7. </label>
                <p>Partial <italic toggle="yes">CACNA1A</italic> deletions and duplications have been described [<xref ref-type="bibr" rid="ea2.REF.labrum.2009.786">Labrum et al 2009</xref>, <xref ref-type="bibr" rid="ea2.REF.rajakulendran.2010.1905">Rajakulendran et al 2010</xref>, <xref ref-type="bibr" rid="ea2.REF.riant.2010.101">Riant et al 2010</xref>]; however, no data on the overall detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="ea2.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ea2.Clinical_Description">
          <title>Clinical Description</title>
          <p>Episodic ataxia type 2 (EA2) demonstrates variable expressivity both among and within families [<xref ref-type="bibr" rid="ea2.REF.denier.1999.1816">Denier et al 1999</xref>]. Episodic ataxia typically starts in childhood or early adolescence (age range 2-32 years) [<xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>]. Onset as late as age 61 years has been reported [<xref ref-type="bibr" rid="ea2.REF.imbrici.2005.944">Imbrici et al 2005</xref>].</p>
          <p>EA2 is characterized by paroxysmal attacks of ataxia, vertigo, and nausea typically lasting hours to days. Attacks can be associated with dysarthria, diplopia, tinnitus, dystonia, hemiplegia, and headache [<xref ref-type="bibr" rid="ea2.REF.nachbauer.2014.983">Nachbauer et al 2014</xref>]. One study reported vertigo and weakness accompanying the ataxia in more than half of individuals with genetically confirmed EA2 [<xref ref-type="bibr" rid="ea2.REF.jen.2004.17">Jen et al 2004</xref>]. Another report suggested that about 50% of individuals with EA2 have migraine headaches without loss of consciousness [<xref ref-type="bibr" rid="ea2.REF.baloh.1997.8">Baloh et al 1997</xref>]. Torticollis, intellectual disability, and psychiatric disorders have been described in individuals with genetically confirmed EA2 [<xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>, <xref ref-type="bibr" rid="ea2.REF.nachbauer.2014.983">Nachbauer et al 2014</xref>].</p>
          <p>Frequency of attacks can range from one to two times per year to three to four times per week [<xref ref-type="bibr" rid="ea2.REF.von_brederlow.1995.279">von Brederlow et al 1995</xref>, <xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>]. Attacks can be triggered by stress, exertion, caffeine, alcohol, and phenytoin. In one kindred, attacks could be provoked by fever or high environmental temperatures [<xref ref-type="bibr" rid="ea2.REF.subramony.2003.725">Subramony et al 2003</xref>]. EA2 attacks can be stopped or decreased in frequency and severity by administration of acetazolamide or 4-aminopyridine [<xref ref-type="bibr" rid="ea2.REF.strupp.2011.269">Strupp et al 2011</xref>, <xref ref-type="bibr" rid="ea2.REF.ilg.2014.248">Ilg et al 2014</xref>]; attacks can recur within 48 to 72 hours of stopping the medication [<xref ref-type="bibr" rid="ea2.REF.von_brederlow.1995.279">von Brederlow et al 1995</xref>]. In some cases, attacks remit within one year after onset but in others, they can recur over a 50-year interval [<xref ref-type="bibr" rid="ea2.REF.baloh.1997.8">Baloh et al 1997</xref>].</p>
          <p>While individuals with EA2 may initially be asymptomatic between attacks, most eventually develop interictal permanent cerebellar symptoms; 90% have nystagmus and about 80% have ataxia. Other interictal findings include pursuit and saccade alterations and dystonia [<xref ref-type="bibr" rid="ea2.REF.spacey.2005.314">Spacey et al 2005</xref>, <xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>].</p>
        </sec>
        <sec id="ea2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Specific <italic toggle="yes">CACNA1A</italic> pathogenic variants do not strictly predict the EA2 phenotype.</p>
          <p>Allelic modifying factors such as number of CAG repeats in exon 47 of CACNA1A do not appear to influence the severity of attacks or the persistence of neurologic symptoms between attacks [<xref ref-type="bibr" rid="ea2.REF.denier.1999.1816">Denier et al 1999</xref>]. Furthermore, the EA2 phenotype in individuals with small intragenic deletions or duplications is similar to that of individuals with pathogenic missense, nonsense, or splice-site variants [<xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>].</p>
          <p>Three pathogenic variants &#x02013; <xref ref-type="table" rid="ea2.T.cacna1a_variants_discussed_in_this">c.3841C&#x0003e;T</xref> (p.Arg1281Ter), <xref ref-type="table" rid="ea2.T.cacna1a_variants_discussed_in_this">c.4217T&#x0003e;G</xref> (p.Phe1406Cys), and <xref ref-type="table" rid="ea2.T.cacna1a_variants_discussed_in_this">c.4645C&#x0003e;T</xref> (p.Arg1549Ter) &#x02013; have been associated with fluctuating weakness manifesting as a myasthenic syndrome in individuals with EA2 [<xref ref-type="bibr" rid="ea2.REF.jen.2001.1843">Jen et al 2001</xref>].</p>
        </sec>
        <sec id="ea2.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is estimated at 80%-90% [<xref ref-type="bibr" rid="ea2.REF.jen.1999.34">Jen et al 1999</xref>, <xref ref-type="bibr" rid="ea2.REF.spacey.2005.314">Spacey et al 2005</xref>].</p>
        </sec>
        <sec id="ea2.Nomenclature">
          <title>Nomenclature</title>
          <p>EA2 has also been known as periodic vestibulocerebellar ataxia and acetazolamide-responsive episodic ataxia.</p>
        </sec>
        <sec id="ea2.Prevalence">
          <title>Prevalence</title>
          <p>EA2 is rare. The Consortium for Clinical Investigation of Neurological Channelopathies (CLINCH) has estimated the prevalence at lower than 1:100,000 population based on the cases seen by experts in regional centers.</p>
        </sec>
      </sec>
      <sec id="ea2.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Pathogenic variants in <italic toggle="yes">CACNA1A</italic> can cause other disorders, including:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter"><bold>Familial hemiplegic migraine</bold></related-object>
<bold>(FHM).</bold> Approximately 50% of families with FHM, including all those with permanent cerebellar symptoms, have heterozygous pathogenic missense variants in <italic toggle="yes">CACNA1A</italic> (FHM1) [<xref ref-type="bibr" rid="ea2.REF.ophoff.1996.543">Ophoff et al 1996</xref>, <xref ref-type="bibr" rid="ea2.REF.ducros.1999.89">Ducros et al 1999</xref>]. Two other FHM-associated genes have been identified; FHM2 is caused by heterozygous pathogenic variants in <italic toggle="yes">ATP1A2</italic> [<xref ref-type="bibr" rid="ea2.REF.de_fusco.2003.192">De Fusco et al 2003</xref>] and FHM3 by heterozygous pathogenic variants in <italic toggle="yes">SCN1A</italic> [<xref ref-type="bibr" rid="ea2.REF.dichgans.2005.371">Dichgans et al 2005</xref>].</p>
            <p>FHM is characterized by an aura of hemiplegia that is always associated with at least one other aura symptom such as hemianopsia, hemisensory deficit, or aphasia. The aura is followed by a moderate to severe headache. Two clinical forms exist: pure FHM (80% of families), in which interictal examination is normal in all family members, and FHM with permanent cerebellar symptoms (20% of families), in which some family members show interictal nystagmus and/or ataxia [<xref ref-type="bibr" rid="ea2.REF.ducros.2001.17">Ducros et al 2001</xref>]. Some individuals with FHM &#x02013; primarily children and adolescents who sustain minor head trauma &#x02013; develop uncontrollable cerebral edema [<xref ref-type="bibr" rid="ea2.REF.mccrory.1998.677">McCrory &#x00026; Berkovic 1998</xref>]. Three individuals with delayed cerebral edema were shown to have the pathogenic p.Ser218Leu missense variant in <italic toggle="yes">CACNA1A</italic> [<xref ref-type="bibr" rid="ea2.REF.kors.2001.753">Kors et al 2001</xref>]. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter"><bold>Spinocerebellar ataxia type 6</bold></related-object>
<bold>(SCA6)</bold> is characterized by adult-onset, slowly progressive cerebellar ataxia, dysarthria, and nystagmus. SCA6 is associated with a CAG expansion in exon 47 of <italic toggle="yes">CACNA1A</italic> [<xref ref-type="bibr" rid="ea2.REF.zhuchenko.1997.62">Zhuchenko et al 1997</xref>]. The normal number of CAG repeats ranges up to 18. Individuals with SCA6 have 20-33 CAG repeats [<xref ref-type="bibr" rid="ea2.REF.matsuyama.1997.1283">Matsuyama et al 1997</xref>]. Inheritance is autosomal dominant.</p>
          </list-item>
        </list>
        <p>Their well-described phenotypes notwithstanding, clinical overlap exists among EA2, FHM, and SCA6, even within the same family.</p>
        <list list-type="bullet">
          <list-item>
            <p>In a family with EA2, affected members had hemiplegia, and one affected member had migraine during episodes of ataxia [<xref ref-type="bibr" rid="ea2.REF.jen.1999.34">Jen et al 1999</xref>].</p>
          </list-item>
          <list-item>
            <p>In a study of 11 individuals with EA2 and documented heterozygous pathogenic variants in<italic toggle="yes">CACNA1A</italic>, four met International Headache Society (HIS) criteria for migraine, but none experienced hemiplegic migraine [<xref ref-type="bibr" rid="ea2.REF.mantuano.2004.e82">Mantuano et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p>Members of a Portuguese family with a pathogenic missense variant (A&#x0003e;G substitution) in <italic toggle="yes">CACNA1A</italic> had either hemiplegic migraine with or without cerebellar signs or permanent ataxia without migraines [<xref ref-type="bibr" rid="ea2.REF.alonso.2003.610">Alonso et al 2003</xref>].</p>
          </list-item>
        </list>
        <p>Individuals with SCA6 can present with episodic ataxia, mostly during the first years of the disorder. In one study, up to 33% of individuals with 21 or more CAG repeats in <italic toggle="yes">CACNA1A</italic> had episodic features prominent enough to warrant the diagnosis of EA2 [<xref ref-type="bibr" rid="ea2.REF.geschwind.1997.1247">Geschwind et al 1997</xref>]. In another family with a CAG repeat expansion, some members had episodic ataxia and others had progressive ataxia; in all affected members, the abnormal allele had 23 CAG repeats [<xref ref-type="bibr" rid="ea2.REF.jodice.1997.1973">Jodice et al 1997</xref>].</p>
      </sec>
      <sec id="ea2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Episodic ataxia can occur sporadically or in a number of hereditary disorders.</p>
        <sec id="ea2.Sporadic_Disorders">
          <title>Sporadic Disorders</title>
          <p>Sporadic causes of episodic ataxia include multiple sclerosis, Arnold Chiari malformation, vertebral basilar insufficiency, basilar migraine, and labyrinthine abnormalities.</p>
        </sec>
        <sec id="ea2.Hereditary_Disorders">
          <title>Hereditary Disorders</title>
          <p><bold>Mitochondrial.</bold> Disorders of mitochondrial oxidative metabolism result in a number of neurologic conditions that are associated with episodic ataxia.</p>
          <list list-type="bullet">
            <list-item>
              <p>The most common of these is <related-object link-type="booklink" source-id="gene" document-id="pdc" document-type="chapter">pyruvate carboxylase deficiency</related-object>. The diagnosis of pyruvate carboxylase (PC) deficiency rests on analysis of amino acids and organic acids and detection of deficient PC enzyme activity measured in cultured fibroblasts. <italic toggle="yes">PC</italic> is the only gene in which mutation is known to cause PC deficiency.</p>
            </list-item>
            <list-item>
              <p>Pyruvate dehydrogenase deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/312170">OMIM</ext-link>) may also present with episodic ataxia and is caused by hemizygous pathogenic variants in the gene encoding the E1-alpha subunit (<italic toggle="yes">PDHA1</italic>) in males or by a heterozygous pathogenic variant in <italic toggle="yes">PDHA1</italic> in a female. See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Diseases Overview</related-object>.</p>
            </list-item>
          </list>
          <p><bold>X-linked.</bold>
<related-object link-type="booklink" source-id="gene" document-id="otc-def" document-type="chapter">Ornithine transcarbamylase (OTC) deficiency</related-object> is an inborn error of metabolism of the urea cycle that causes hyperammonemia. Identification of a hemizygous pathogenic variant <italic toggle="yes">OTC</italic> in males can confirm the diagnosis. A heterozygous pathogenic variant in <italic toggle="yes">OTC</italic> in a female may lead to partial deficiency. Severely affected males die in the neonatal period and females have varying clinical manifestations ranging from no symptoms to severe deficits. Symptoms can include episodic extreme irritability (100%), episodic vomiting and lethargy (100%), protein avoidance (92%), ataxia (77%), stage II coma (46%), delayed growth (38%), developmental delay (38%), and seizures (23%). OTC deficiency is treatable with supplemental dietary arginine and a low-protein diet.</p>
          <p>
            <bold>Autosomal recessive</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Hyperammonemias caused by deficiencies of urea cycle enzymes</bold> include carbamoylphosphate synthetase deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/237300">OMIM</ext-link>), argininosuccinate synthetase deficiency (<related-object link-type="booklink" source-id="gene" document-id="ctlm" document-type="chapter">citrullinemia type 1</related-object>), <related-object link-type="booklink" source-id="gene" document-id="args-aciduria" document-type="chapter">argininosuccinase deficiency</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="arg1" document-type="chapter">arginase deficiency</related-object>. See <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">Urea Cycle Disorders Overview</related-object>.</p>
              <p>The identification of a significantly elevated blood ammonia concentration requires immediate treatment by hemodialysis and by IV sodium phenylacetate/sodium benzoate; long-term treatment of urea cycle disorders generally includes a high-calorie, low-protein diet supplemented with essential amino acids.</p>
              <p>The severe forms of the hyperammonemias present in the first few days of life with lethargy and possible focal and generalized seizures, ultimately leading to coma. The less severe forms develop in early childhood and are characterized by intermittent ataxia, dysarthria, vomiting, headache, ptosis, involuntary movements, seizures, and confusion. These episodes are precipitated by high protein loads and intercurrent illness. Children with argininosuccinase deficiency often have distinctive facial features and brittle hair.</p>
            </list-item>
            <list-item>
              <p><bold>Aminoacidurias,</bold> including Hartnup disease, intermittent branched-chain ketoaciduria, and isovaleric acidemia, can be diagnosed by identification of increased levels of certain amino acids in plasma and increased excretion of amino acids in the urine.</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Hartnup disease</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/234500">OMIM</ext-link>) results from defective renal and intestinal transport of monoaminomonocarboxylic acids giving rise to intermittent ataxia, tremor, chorea, and psychiatric disturbances; intellectual disability; and pellagra-like rash. Episodes are triggered by exposure to sunlight, emotional stress, and sulfonamide drugs. Attacks last about two weeks, followed by relative normalcy. The frequency of attacks diminishes with maturation. Treatment is oral administration of nicotinamide.</p>
                </list-item>
                <list-item>
                  <p><bold>Intermittent branched-chain ketoaciduria</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/248600">OMIM</ext-link>) is characterized by intermittent transient ataxia, intellectual disability, physical developmental delay, feeding problems, and elevation of branched-chain amino acids and keto acids in the urine as well as a distinctive odor of maple syrup to the urine. This condition is treated by the elimination of branched-chain amino acids (leucine, isoleucine, valine) from the diet. A variant of this condition may be effectively treated with thiamine. See <related-object link-type="booklink" source-id="gene" document-id="msud" document-type="chapter">Maple Syrup Urine Disease</related-object>.</p>
                </list-item>
                <list-item>
                  <p><bold>Isovaleric acidemia</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/243500">OMIM</ext-link>) occurs in two forms. The acute neonatal form is associated with urine that has a sweaty foot odor and massive metabolic acidosis in the first days of life followed by rapid death. The chronic form is associated with periodic attacks of severe ketoacidosis between asymptomatic periods. Treatment consists of protein restriction and supplementation with glycine and carnitine.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Autosomal dominant</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="ea1" document-type="chapter"><bold>Episodic ataxia type 1</bold></related-object>
<bold>(EA1)</bold> is caused by heterozygous pathogenic variants in <italic toggle="yes">KCNA1,</italic> a potassium channel. EA1, also called ataxia with myokymia, is characterized by brief attacks (&#x0003c;15 minutes) of ataxia and dysarthria that can occur up to 15 times per day. Attacks can occur spontaneously or be triggered by anxiety, exercise, startle, and/or intercurrent illness. Onset is typically in late childhood and early adolescence; symptoms usually remit in the second decade. Between attacks, widespread myokymia of the face, hands, arms, and legs occurs [<xref ref-type="bibr" rid="ea2.REF.vandyke.1975.109">VanDyke et al 1975</xref>, <xref ref-type="bibr" rid="ea2.REF.hanson.1977.120">Hanson et al 1977</xref>, <xref ref-type="bibr" rid="ea2.REF.gancher.1986.239">Gancher &#x00026; Nutt 1986</xref>]. Electromyographic studies reveal myokymia (neuromyotonia). Phenytoin can control symptoms; acetazolamide is also effective [<xref ref-type="bibr" rid="ea2.REF.lubbers.1995.400">Lubbers et al 1995</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Episodic ataxia type 3 (EA3)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/606554">OMIM</ext-link>) has been described in a large Canadian Mennonite family [<xref ref-type="bibr" rid="ea2.REF.steckley.2001.1499">Steckley et al 2001</xref>]. EA3 is characterized by brief acetazolamide-responsive attacks of vestibular ataxia, vertigo, tinnitus, and interictal myokymia. Interictal nystagmus and ataxia are not present. The age of onset is variable. The causative locus has been mapped to a 4 cM region on chromosome 1q42 between markers D1S2712 and D1S2678 [<xref ref-type="bibr" rid="ea2.REF.steckley.2001.1499">Steckley et al 2001</xref>, <xref ref-type="bibr" rid="ea2.REF.cader.2005.156">Cader et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Episodic ataxia type 4 (EA4)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/606552">OMIM</ext-link>) has been described in two families of European ancestry from rural North Carolina [<xref ref-type="bibr" rid="ea2.REF.farmer.1963.471">Farmer &#x00026; Mustian 1963</xref>, <xref ref-type="bibr" rid="ea2.REF.vance.1984.78s">Vance et al 1984</xref>]. EA4 is characterized by attacks of vertigo, diplopia, and ataxia beginning in early adulthood. In some individuals, slowly progressive cerebellar ataxia occurs.</p>
            </list-item>
            <list-item>
              <p><bold>Episodic ataxia type 5 (EA5)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/613855">OMIM</ext-link>) can result from a heterozygous pathogenic variant in <italic toggle="yes">CACNB4,</italic> which encodes the beta-4 isoform of the regulatory beta subunit of voltage-activated Ca(2+) channels. A p.Cys104Phe pathogenic variant has been described in a French-Canadian family [<xref ref-type="bibr" rid="ea2.REF.escayg.2000.1531">Escayg et al 2000</xref>]. The phenotype was characterized by recurrent episodes of vertigo and ataxia that lasted for several hours. Interictal examination showed spontaneous downbeat and gaze-evoked nystagmus and mild dysarthria and truncal ataxia. Acetazolamide prevented the attacks.</p>
            </list-item>
            <list-item>
              <p><bold>Episodic ataxia type 6 (EA6)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/612656">OMIM</ext-link>) results from heterozygous pathogenic variants in <italic toggle="yes">SLC1A3</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/600111#0002">OMIM</ext-link>). Cellular studies showed that the pathogenic variant results in decreased glutamate uptake [<xref ref-type="bibr" rid="ea2.REF.jen.2005.529">Jen et al 2005</xref>, <xref ref-type="bibr" rid="ea2.REF.de_vries.2009.97">de Vries et al 2009</xref>]. The phenotype correlates with the extent of glutamate transporter dysfunction [deVries et al 2009] and, as a result, the phenotype is quite variable. <xref ref-type="bibr" rid="ea2.REF.jen.2005.529">Jen et al [2005]</xref> reported a boy age ten years with a severe form of episodic ataxia with seizures, migraine, and alternating hemiplegia triggered by febrile illness. There was interictal truncal ataxia. In contrast, <xref ref-type="bibr" rid="ea2.REF.de_vries.2009.97">de Vries et al [2009]</xref> reported a Dutch family with onset in the first or second decade and attacks of ataxia lasting two to three hours associated with nausea, vomiting, photophobia, phonophobia, vertigo, diplopia, and/or slurred speech. Headaches were not a prominent feature and there was no interictal truncal ataxia. Attacks were provoked by emotional stress, fatigue, or consumption of alcohol or caffeine. The attacks could be reduced with acetazolamide.</p>
            </list-item>
            <list-item>
              <p><bold>Episodic ataxia type 7 (EA7)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/611907">OMIM</ext-link>) has been linked to a 10-cM candidate region, between <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/Variation/Summary?v=rs1366444;expand=HGVS_names">rs1366444</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/Variation/Summary?v=rs952108;expand=HGVS_names">rs952108</ext-link> on chromosome 19q13 (maximum lod score of 3.28). No pathogenic variants were identified in <italic toggle="yes">KCNC3</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/176264">OMIM</ext-link>) or <italic toggle="yes">SLC17A7</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/605208">OMIM</ext-link>). The phenotype was characterized by onset before age 20 years, attacks lasting hours to days, and associated weakness and dysarthria. Triggers included exercise and excitement. Two affected family members reported vertigo during attacks. Frequency ranged from monthly to yearly and tended to decrease with age. Two affected family members had migraine headaches that were not associated with episodic ataxia. No interictal findings were observed on neurologic examination [<xref ref-type="bibr" rid="ea2.REF.kerber.2007.749">Kerber et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter"><bold>Spinocerebellar ataxia type 6</bold></related-object>
<bold>(SCA6)</bold> (See also <xref ref-type="sec" rid="ea2.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>.)</p>
            </list-item>
          </list>
          <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS160120">Episodic ataxia: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        </sec>
      </sec>
      <sec id="ea2.Management">
        <title>Management</title>
        <sec id="ea2.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with episodic ataxia type 2 (EA2), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination for signs of interictal ataxia and nystagmus</p>
            </list-item>
            <list-item>
              <p>Neuroimaging of the head (if not performed already), preferably MRI, to evaluate for structural lesions and to look for evidence of atrophy</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="ea2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Acetazolamide</bold> is effective in controlling or reducing the frequency and severity of attacks in two thirds of individuals with EA2 [<xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>, <xref ref-type="bibr" rid="ea2.REF.ilg.2014.248">Ilg et al 2014</xref>]. The typical starting dose is 125 mg/day given orally, but doses as high as 500 mg/2x/day may be required. This medication is generally well tolerated; the most common side effects are paresthesias of the extremities, rash, and renal calculi.</p>
          <p><bold>4-aminopyridine,</bold> a potassium channel blocker, also reduces attack frequency and duration at doses of 5-10 mg/3x/day [<xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>, <xref ref-type="bibr" rid="ea2.REF.strupp.2011.269">Strupp et al 2011</xref>].</p>
          <p>Generally acetazolomide is used as the firstline therapy, although there are no specific recommendations regarding which medication should be trialed first [<xref ref-type="bibr" rid="ea2.REF.ilg.2014.248">Ilg et al 2014</xref>].</p>
        </sec>
        <sec id="ea2.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Treatment with acetazolamide does not appear to prevent the progression of interictal symptoms [<xref ref-type="bibr" rid="ea2.REF.baloh.1991.429">Baloh &#x00026; Winder 1991</xref>]. It is not clear how acetazolamide prevents attacks of EA2, although <xref ref-type="bibr" rid="ea2.REF.yue.1997.1078">Yue et al [1997]</xref> speculated that the mechanism involves a decrease in pH, thus inhibiting ion permeation through open calcium channels. Acetazolamide could stabilize channels that fail to properly inactivate. Acetazolamide may not work in some individuals, particularly if the pathogenic variant distorts the pore region of the channel, altering the stabilizing effect of H+ ions.</p>
          <p>To date no data regarding whether 4-aminopyridine can prevent the progression of interictal symptoms are available.</p>
        </sec>
        <sec id="ea2.Surveillance">
          <title>Surveillance</title>
          <p>Surveillance should include annual neurologic examination.</p>
        </sec>
        <sec id="ea2.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Phenytoin has been reported to exacerbate symptoms.</p>
        </sec>
        <sec id="ea2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ea2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ea2.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>There is limited published literature addressing the management of the pregnancy of an affected woman or the effect of maternal EA2 on a fetus. However, because physical exertion can trigger attacks, it would be prudent for a pregnant woman to be followed closely by her obstetrician and at term to undergo a trial of labor with the intent to proceed to delivery by C-section should the labor trigger an EA2 attack [<xref ref-type="bibr" rid="ea2.REF.spacey.2012.s3">Spacey 2012</xref>].</p>
        </sec>
        <sec id="ea2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><xref ref-type="bibr" rid="ea2.REF.scoggan.2006.68">Scoggan et al [2006]</xref> reported an individual who responded to a combination of acetazolamide and valproic acid.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ea2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ea2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Episodic ataxia type 2 (EA2) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="ea2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with EA2 have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with EA2 may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">CACNA1A</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are <italic toggle="yes">de novo</italic> mutation in the proband or germline mosaicism in a parent Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include neurologic examination, head MRI, and EMG.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with EA2 may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance, early death of the parent before the onset of symptoms, or late onset of the disorder in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of a proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>Since EA2 demonstrates incomplete penetrance, a clinically unaffected parent may have a heterozygous <italic toggle="yes">CACNA1A</italic> pathogenic variant and the sibs of the proband may still be at 50% risk.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">CACNA1A</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism. Germline mosaicism has not been reported to date.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with EA2 has a 50% chance of inheriting the <italic toggle="yes">CACNA1A</italic> pathogenic variant. Since EA2 demonstrates incomplete penetrance, it is not possible to predict the age of onset, symptoms, or progression of disease in an individual.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the genetic status of the proband's parents: if a parent is affected or has the pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="ea2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with EA2 has the pathogenic variant or clinical evidence of the disorder, the <italic toggle="yes">CACNA1A</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, other possible non-medical explanations that could be explored include alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ea2.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CACNA1A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for EA2 are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="ea2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ea2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Multiple transcript variants encoding different isoforms have been found for <italic toggle="yes">CACNA1A</italic>. The variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_023035.2">NM_023035.2</ext-link> represents the longest transcript and encodes the longest isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_075461.2">NP_075461.2</ext-link>. The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_023035.2">NM_023035.2</ext-link> consists of 48 exons and includes a (CAG)n-repeat in the coding region, resulting in a polyglutamine tract near the C-terminus. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ea2" object-id="ea2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 50 different <italic toggle="yes">CACNA1A</italic> pathogenic variants associated with EA2 have been described [<xref ref-type="bibr" rid="ea2.REF.ophoff.1996.543">Ophoff et al 1996</xref>, <xref ref-type="bibr" rid="ea2.REF.yue.1997.1078">Yue et al 1997</xref>, <xref ref-type="bibr" rid="ea2.REF.yue.1998.298">Yue et al 1998</xref>, <xref ref-type="bibr" rid="ea2.REF.denier.1999.1816">Denier et al 1999</xref>, <xref ref-type="bibr" rid="ea2.REF.friend.1999.261">Friend et al 1999</xref>, <xref ref-type="bibr" rid="ea2.REF.denier.2001.292">Denier et al 2001</xref>, <xref ref-type="bibr" rid="ea2.REF.van_den_maagdenberg.2002.1515">van den Maagdenberg et al 2002</xref>, <xref ref-type="bibr" rid="ea2.REF.matsuyama.2003.91">Matsuyama et al 2003</xref>, <xref ref-type="bibr" rid="ea2.REF.subramony.2003.725">Subramony et al 2003</xref>, <xref ref-type="bibr" rid="ea2.REF.jen.2004.17">Jen et al 2004</xref>, <xref ref-type="bibr" rid="ea2.REF.kaunisto.2004.69">Kaunisto et al 2004</xref>, <xref ref-type="bibr" rid="ea2.REF.mantuano.2004.e82">Mantuano et al 2004</xref>, <xref ref-type="bibr" rid="ea2.REF.spacey.2004.213">Spacey et al 2004</xref>, <xref ref-type="bibr" rid="ea2.REF.spacey.2005.314">Spacey et al 2005</xref>, <xref ref-type="bibr" rid="ea2.REF.mantuano.2010.30">Mantuano et al 2010</xref>, <xref ref-type="bibr" rid="ea2.REF.nachbauer.2014.983">Nachbauer et al 2014</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>The majority of the pathogenic variants in <italic toggle="yes">CACNA1A</italic> are nonsense or small insertion and/or deletion (indel) variants that disrupt the open reading frame leading to truncation of the protein. Intronic variants that presumably disrupt the reading frame through abnormal splicing (exon skipping or intron inclusion) of the gene product have also been reported [<xref ref-type="bibr" rid="ea2.REF.eunson.2005.308">Eunson et al 2005</xref>, <xref ref-type="bibr" rid="ea2.REF.wan.2005.131">Wan et al 2005</xref>]. However, 21 <italic toggle="yes">CACNA1A</italic> pathogenic variants do not disrupt the reading frame, including 18 pathogenic missense variants resulting in substitutions of conserved amino acids mostly located in the pore regions of the channel [<xref ref-type="bibr" rid="ea2.REF.pietrobon.2010.375">Pietrobon 2010</xref>]. A number of pathogenic non-truncating variants that appear to cluster in the S5-S6 linkers and their borders have also been described [<xref ref-type="bibr" rid="ea2.REF.mantuano.2004.e82">Mantuano et al 2004</xref>, <xref ref-type="bibr" rid="ea2.REF.spacey.2004.213">Spacey et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p>Large-scale exon deletions or duplications involving one or more exons in <italic toggle="yes">CACNA1A</italic> have been reported in several families with EA2 [<xref ref-type="bibr" rid="ea2.REF.labrum.2009.786">Labrum et al 2009</xref>, <xref ref-type="bibr" rid="ea2.REF.riant.2010.101">Riant et al 2010</xref>]. The rearrangements are likely to be pathogenic given their segregation with the disease in large families with EA2.</p>
          </list-item>
        </list>
        <table-wrap id="ea2.T.cacna1a_variants_discussed_in_this" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">CACNA1A</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3841C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1281Ter</td>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_023035.2">NM_023035.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_075461.2">NP_075461.2</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4217T&#x0003e;G&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe1406Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4645C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_ea2.T.cacna1a_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1549Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="ea2.TF.2.1">
              <label>1. </label>
              <p>Associated with fluctuating weakness manifesting as a myasthenic syndrome in individuals with EA2 [<xref ref-type="bibr" rid="ea2.REF.jen.2001.1843">Jen et al 2001</xref>]. See <xref ref-type="sec" rid="ea2.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">CACNA1A</italic> encodes an &#x003b1;<sub>1A</sub> subunit that serves as the pore-forming subunit of a voltage-dependent P/Q-type calcium channel [<xref ref-type="bibr" rid="ea2.REF.hofmann.1994.399">Hofmann et al 1994</xref>, <xref ref-type="bibr" rid="ea2.REF.greenberg.1997.275">Greenberg 1997</xref>]. Voltage-dependent calcium channels are made up of the pore-forming alpha1 subunit and accessory subunits alpha2-delta, beta, and gamma. The &#x003b1;<sub>1A</sub> subunits are membrane glycoproteins of approximately 2400 amino acids in length in which primary structure predicts the presence of four homologous domains, each consisting of six transmembrane domains and a pore-forming P loop. P/Q-type calcium channels are high voltage-activated calcium channels that are found primarily on neurons and are expressed at high levels in granule cells and Purkinje cells of the cerebellar cortex. Their principal role is believed to be in synaptic transmission. The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_075461.2">NP_075461.2</ext-link> isoform has 2512 amino acids. The function of the different <italic toggle="yes">CACNA1A</italic> isoforms remains to be demonstrated, although differences have been measured in phosphorylation acceptor sites [<xref ref-type="bibr" rid="ea2.REF.sakurai.1996.511">Sakurai et al 1996</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">CACNA1A</italic> appear to cause a loss of function.</p>
      </sec>
      <sec id="ea2.References">
        <title>References</title>
        <sec id="ea2.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="ea2.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="ea2.REF1">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>; registration or institutional access required. 2010. Accessed 2-2-17.</mixed-citation>
            </ref>
            <ref id="ea2.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 2-2-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ea2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ea2.Literature_Cited.reflist0">
            <ref id="ea2.REF.alonso.2003.610">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silveira</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>610</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12707077</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.bain.1992.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bain</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keevil</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis.</article-title>
                <source>Ann Neurol</source>
                <volume>31</volume>
                <fpage>147</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">1575453</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.baloh.1991.429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winder</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features.</article-title>
                <source>Neurology</source>
                <volume>41</volume>
                <fpage>429</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">2006014</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.baloh.1997.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p.</article-title>
                <source>Ann Neurol</source>
                <volume>41</volume>
                <fpage>8</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9005860</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.cader.2005.156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cader</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steckley</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyment</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLachlan</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebers</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <article-title>A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>156</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16009908</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.de_fusco.2003.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atorino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>192</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12539047</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.de_vries.2009.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamsa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake.</article-title>
                <source>Arch Neurol.</source>
                <volume>66</volume>
                <fpage>97</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">19139306</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.denier.2001.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chassande</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Missense CACNA1A mutation causing episodic ataxia type 2.</article-title>
                <source>Arch Neurol</source>
                <volume>58</volume>
                <fpage>292</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11176968</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.denier.1999.1816">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thierry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnovo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deonna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devoize</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrouty</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soisson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warter</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vighetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roullet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2.</article-title>
                <source>Neurology</source>
                <volume>52</volume>
                <fpage>1816</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10371528</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.dichgans.2005.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckstein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz-Depiereux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.</article-title>
                <source>Lancet</source>
                <volume>366</volume>
                <fpage>371</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16054936</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.ducros.2001.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecillon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darcel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicaut</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.</article-title>
                <source>N Engl J Med</source>
                <volume>345</volume>
                <fpage>17</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">11439943</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.ducros.1999.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darcel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madigand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerouaou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chedru</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucotte</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Despres</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barthez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>89</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">9915947</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.escayg.2000.1531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escayg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Waard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bichet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meisler</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>66</volume>
                <fpage>1531</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10762541</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.eunson.2005.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eunson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graves</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>New calcium channel mutations predict aberrant RNA splicing in episodic ataxia.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>308</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">16043807</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.farmer.1963.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farmer</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mustian</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <year>1963</year>
                <article-title>Vestibulo-cerebellar ataxia: a newly defined hereditary syndrome with periodic manifestations.</article-title>
                <source>Arch Neurol</source>
                <volume>8</volume>
                <fpage>471</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">13944410</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.friend.1999.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friend</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crimmins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phan</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colley</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>RI</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM.</article-title>
                <source>Hum Genet</source>
                <volume>105</volume>
                <fpage>261</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10987655</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.gancher.1986.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gancher</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Autosomal dominant episodic ataxia: a heterogeneous syndrome.</article-title>
                <source>Mov Disord</source>
                <volume>1</volume>
                <fpage>239</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">3504247</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.gasser.2010.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finsterer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lossos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szolnoki</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabrizi</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tallaksen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgunder</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbo</surname>
                    <given-names>HF</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias.</article-title>
                <source>Eur J Neurol.</source>
                <year>2010</year>
                <volume>17</volume>
                <fpage>179</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">20050888</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.geschwind.1997.1247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karrim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1247</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">9371902</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.greenberg.1997.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Calcium channels in neurological disease.</article-title>
                <source>Ann Neurol</source>
                <volume>42</volume>
                <fpage>275</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">9307247</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.hanson.1977.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanson</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassidy</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Contractures, continuous muscle discharges, and titubation.</article-title>
                <source>Ann Neurol</source>
                <volume>1</volume>
                <fpage>120</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">889293</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.harno.2005.542">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heikkinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaunisto</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakkinen</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farkkila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundbom</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Decreased cerebellar total creatine in episodic ataxia type 2: a 1H MRS study.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>542</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15699392</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.hofmann.1994.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flockerzi</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Molecular basis for Ca2+ channel diversity.</article-title>
                <source>Annu Rev Neurosci</source>
                <volume>17</volume>
                <fpage>399</fpage>
                <lpage>418</lpage>
                <pub-id pub-id-type="pmid">8210181</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.imbrici.2005.944">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imbrici</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graves</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadia</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kullmann</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>944</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16186543</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.ilg.2014.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastian</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boesch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burciu</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celnik</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claa&#x000df;en</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalla</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyai</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nachbauer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strupp</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teufel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmann</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Consensus paper: management of degenerative cerebellar disorders.</article-title>
                <source>Cerebellum.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>248</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">24222635</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.jen.2004.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clinical spectrum of episodic ataxia type 2.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>17</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">14718690</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.jen.2001.1843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graves</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mock</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulin</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papazian</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>1843</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11723274</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.jen.1999.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>34</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10408533</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.jen.2005.529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palos</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.</article-title>
                <source>Neurology.</source>
                <volume>65</volume>
                <fpage>529</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">16116111</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.jodice.1997.1973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jodice</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantuano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veneziano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trettel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabbadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandriello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadaro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frontali</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1973</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9302278</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.kaunisto.2004.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaunisto</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallinen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miettinen</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vesa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orpana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farkkila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Novel splice site CACNA1A mutation causing episodic ataxia type 2.</article-title>
                <source>Neurogenetics</source>
                <volume>5</volume>
                <fpage>69</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">14530926</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.kerber.2007.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kerber</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A new episodic ataxia syndrome with linkage to chromosome 19q13.</article-title>
                <source>Arch Neurol.</source>
                <volume>64</volume>
                <fpage>749</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17502476</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.kors.2001.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzsimons</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardine</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heywood</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>753</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11409427</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.labrum.2009.786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Labrum</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajakulendran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graves</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tubridy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britton</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Memar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kullmann</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorge</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.</article-title>
                <source>J Med Genet.</source>
                <volume>46</volume>
                <fpage>786</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19586927</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.lubbers.1995.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lubbers</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunt</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stulp</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Browne</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Weerden</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>59</volume>
                <fpage>400</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7561920</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.mantuano.2010.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mantuano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veneziano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellotti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caimi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estienne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajabally</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barcina</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frontali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.</article-title>
                <source>J Neurol Sci.</source>
                <volume>291</volume>
                <fpage>30</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20129625</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.mantuano.2004.e82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mantuano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veneziano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadaro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leggio</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verriello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jodice</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frontali</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Ca(v)2.1 causing episodic ataxia 2.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e82</fpage>
                <pub-id pub-id-type="pmid">15173248</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.matsuyama.2003.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuyama</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murase</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hozumi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inuzuka</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A novel insertion mutation of acetazolamide-responsive episodic ataxia in a Japanese family.</article-title>
                <source>J Neurol Sci</source>
                <volume>210</volume>
                <fpage>91</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12736095</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.matsuyama.1997.1283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuyama</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komure</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kameyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishio</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6).</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1283</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9259274</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.mccrory.1998.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCrory</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Second impact syndrome.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>677</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">9521255</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.nachbauer.2014.983">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nachbauer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nocker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanovic</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unterberger</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eigentler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poese</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delazer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boesch</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A jutation and review of the literature.</article-title>
                <source>J Neurol</source>
                <year>2014</year>
                <volume>261</volume>
                <fpage>983</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">24658662</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.ophoff.1996.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergouwe</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Eijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oefner</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamerdin</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohrenweiser</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindhout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofker</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.</article-title>
                <source>Cell</source>
                <volume>87</volume>
                <fpage>543</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">8898206</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.pietrobon.2010.375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pietrobon</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>CaV2.1 channelopathies.</article-title>
                <source>Pflugers Arch.</source>
                <year>2010</year>
                <volume>460</volume>
                <fpage>375</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">20204399</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.rajakulendran.2010.1905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajakulendran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graves</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labrum</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotzadimitriou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kullmann</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorge</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.</article-title>
                <source>J Physiol.</source>
                <volume>588</volume>
                <fpage>1905</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">20156848</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.riant.2010.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaphan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soisson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiener-Vacher</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Identification of CACNA1A large deletions in four patients with episodic ataxia.</article-title>
                <source>Neurogenetics.</source>
                <volume>11</volume>
                <fpage>101</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19633872</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.sakurai.1996.511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sakurai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westenbroek</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rettig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Biochemical properties and subcellular distribution of the BI and rbA isoforms of alpha 1A subunits of brain calcium channels.</article-title>
                <source>J Cell Biol</source>
                <volume>134</volume>
                <fpage>511</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">8707834</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.scoggan.2006.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scoggan</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid.</article-title>
                <source>Can J Neurol Sci</source>
                <volume>33</volume>
                <fpage>68</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16583725</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.spacey.2012.s3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spacey</surname>
                    <given-names>SD</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Episodic ataxia type 2 and pregnancy.</article-title>
                <source>Can J Neurol Sci.</source>
                <volume>39</volume>
                <fpage>S3</fpage>
                <lpage>S19</lpage>
              </element-citation>
            </ref>
            <ref id="ea2.REF.spacey.2004.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spacey</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Materek</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snutch</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.</article-title>
                <source>Ann Neurol</source>
                <volume>56</volume>
                <fpage>213</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15293273</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.spacey.2005.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spacey</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Materek</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczygielski</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>314</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15710862</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.steckley.2001.1499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steckley</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebers</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cader</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLachlan</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>1499</fpage>
                <lpage>502</lpage>
                <pub-id pub-id-type="pmid">11673600</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.strupp.2011.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strupp</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalla</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claassen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adrion</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansmann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neugebauer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkat-Rott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahn</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.</article-title>
                <source>Neurology.</source>
                <year>2011</year>
                <volume>77</volume>
                <fpage>269</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">21734179</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.subramony.2003.725">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Subramony</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raike</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callahan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langford</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christova</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>725</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">14681882</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.van_den_maagdenberg.2002.1515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunt</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Paesschen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravine</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeling</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene.</article-title>
                <source>J Neurol</source>
                <volume>249</volume>
                <fpage>1515</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12420090</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.vance.1984.78s">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coin</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olanow</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Linkage and genetic analysis in adult onset periodic vestibulo-cerebellar ataxia: report of a new family.</article-title>
                <source>Am J Hum Genet</source>
                <volume>36</volume>
                <fpage>78S</fpage>
              </element-citation>
            </ref>
            <ref id="ea2.REF.vandyke.1975.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>VanDyke</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>MN</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>Hereditary myokymia and periodic ataxia.</article-title>
                <source>J Neurol Sci</source>
                <volume>25</volume>
                <fpage>109</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">1170284</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.vighetto.1988.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vighetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froment</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trillet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aimard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Magnetic resonance imaging in familial paroxysmal ataxia.</article-title>
                <source>Arch Neurol</source>
                <volume>45</volume>
                <fpage>547</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3358708</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.von_brederlow.1995.279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>von Brederlow</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koopman</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebers</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p.</article-title>
                <source>Hum Mol Genet</source>
                <volume>4</volume>
                <fpage>279</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">7757080</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.wan.2005.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Nonconsensus intronic mutations cause episodic ataxia.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>131</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15622542</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.yue.1997.1078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Progressive ataxia due to a missense mutation in a calcium-channel gene.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>1078</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">9345107</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.yue.1998.298">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thwe</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.</article-title>
                <source>Am J Med Genet</source>
                <volume>77</volume>
                <fpage>298</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">9600739</pub-id>
              </element-citation>
            </ref>
            <ref id="ea2.REF.zhuchenko.1997.62">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhuchenko</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockton</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramony</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.</article-title>
                <source>Nat Genet</source>
                <volume>15</volume>
                <fpage>62</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8988170</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ea2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ea2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 October 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 December 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 June 2009 (cd) Revision: <italic toggle="yes">CACNB4</italic> mutations associated with episodic ataxia type 5</p>
            </list-item>
            <list-item>
              <p>24 March 2009 (cd) Revision: deletion/duplication analysis available clinically for CACNA1A</p>
            </list-item>
            <list-item>
              <p>17 December 2007 (cd) Revision: prenatal testing available for CACNA1A-related EA2</p>
            </list-item>
            <list-item>
              <p>12 April 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 January 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 December 2003 (me) Revision: change in test availability</p>
            </list-item>
            <list-item>
              <p>24 February 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 August 2002 (ss) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
